Journal
CANCER COMMUNICATIONS
Volume 41, Issue 10, Pages 981-1006Publisher
WILEY
DOI: 10.1002/cac2.12194
Keywords
drug delivery; drug resistance; long non-coding RNAs; microRNAs; non-coding RNA (ncRNA); oral squamous cell carcinoma
Categories
Funding
- National Natural Science Foundation of China [81700522]
- Natural Science Foundation of Anhui Province [1808085MH235, 1908085QH328]
- Anhui Medical University [XJ201706]
Ask authors/readers for more resources
Oral squamous cell carcinoma (OSCC) is influenced by multiple factors including tobacco and alcohol consumption. Nano-delivery and self-cellular drug delivery platforms are effective strategies to overcome drug resistance, while the application of new technologies opens up new opportunities for the treatment of drug resistance.
Oral squamous cell carcinoma (OSCC), the eighth most prevalent cancer in the world, arises from the interaction of multiple factors including tobacco, alcohol consumption, and betel quid. Chemotherapeutic agents such as cisplatin, 5-fluorouracil, and paclitaxel have now become the first-line options for OSCC patients. Nevertheless, most OSCC patients eventually acquire drug resistance, leading to poor prognosis. With the discovery and identification of non-coding RNAs (ncRNAs), the functions of dysregulated ncRNAs in OSCC development and drug resistance are gradually being widely recognized. The mechanisms of drug resistance of OSCC are intricate and involve drug efflux, epithelial-mesenchymal transition, DNA damage repair, and autophagy. At present, strategies to explore the reversal of drug resistance of OSCC need to be urgently developed. Nano-delivery and self-cellular drug delivery platforms are considered as effective strategies to overcome drug resistance due to their tumor targeting, controlled release, and consistent pharmacokinetic profiles. In particular, the combined application of new technologies (including CRISPR systems) opened up new horizons for the treatment of drug resistance of OSCC. Hence, this review explored emerging regulatory functions of ncRNAs in drug resistance of OSCC, elucidated multiple ncRNA-meditated mechanisms of drug resistance of OSCC, and discussed the potential value of drug delivery platforms using nanoparticles and self-cells as carriers in drug resistance of OSCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available